Skip to content
WorkingMomRx
Menu

Heads up: some links below are affiliate links — assume any provider we list may compensate us, at no cost to you. It never buys a better score, but the providers we work with are listed first. See our affiliate disclosure.

Head-to-head

CoreAge Rx vs Zealthy

CoreAge Rx and Zealthy both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.

CoreAge Rx

Higher score

Ranked #1 · Grade A

Best for: Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.

Visit CoreAge Rx
vs

Zealthy

Ranked #298 · Grade C

Best for: Nothing, while the federal case is open. It stays on the board for transparency, not as a suggestion.

Visit Zealthy

The verdict

Higher Rx-Readiness Score: CoreAge Rx

CoreAge Rx edges out Zealthy on the Rx-Readiness Score, 95 to 39 (A vs C). Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.

Zealthy is still a genuine option — fDA warning letter #716501 (September 2025), which names getzealthy.com, and in April 2026 the FTC and DOJ moved to seize the company and freeze its assets. Read both before anything else here. On the money: read live on 26 August 2026, self-pay semaglutide is advertised at "as little as $151/month" and brand Ozempic, Wegovy, Zepbound and Mounjaro at "as low as $25/month" with insurance — two figures that are not comparable, because the second is a copay that depends on your plan and the same paragraph quotes $1,349 without coverage. No tirzepatide price is published anywhere. A "$96 off your first month" banner runs site-wide and its own policy confirms the rate reverts to full afterward. Cancellation is self-serve and documented step by step, but there is no prorated refund, medication is final once shipped, and the policy warns members may be required to sign up for multiple months to keep supply continuous. Four months after the federal petition it is still trading normally under the same entity, FitRX, LLC dba Zealthy, at the same New York address the FDA letter used. Weigh the six readiness factors below against your own priorities.

Side-by-side on the six factors

Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.

CoreAge Rx Zealthy
Time to first dose9562
CoreAge
Zealthy
Flat, predictable pricing9725
CoreAge
Zealthy
No-video (async) intake9530
CoreAge
Zealthy
Nationwide access9630
CoreAge
Zealthy
Both molecules on one plan9562
CoreAge
Zealthy
Easy off-ramp9222
CoreAge
Zealthy

Price, access & features

DetailCoreAge RxZealthy
Rx-Readiness Score95/100 · A39/100 · C
Overall rank#1#298
Semaglutide$99/moFrom $151/mo self-pay
Tirzepatide$149/moNot priced on the public site
CoverageAll 50 statesNot published on the public site
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only

CoreAge Rx

Ranked #1 · Grade A

What we like

  • Flat monthly price that stays put through titration — no dose-scaling surprise on your busiest month
  • Both compounded semaglutide and tirzepatide on one plan, so you're not re-signing to switch
  • Async, no-video intake and all-50-states coverage — start it during a lunch break

The caveats

  • Not the rock-bottom sticker price — a couple of teaser tiers elsewhere start lower
  • Compounded only — no FDA-approved brand option
  • General metabolic program, not a boutique concierge service

Zealthy

Ranked #298 · Grade C

What we like

  • Both self-pay and insured figures are published on the public page before any form
  • Brand Ozempic, Wegovy, Zepbound and Mounjaro sit on the menu alongside compounded semaglutide, and it works with major insurers
  • Same-day appointments are advertised, and the published intake takes about five minutes before the visit

The caveats

  • April 2026: the FTC and DOJ asked a federal court to place Zealthy in receivership and freeze its assets, alleging deceptive disclosures, obstructive cancellation and review manipulation
  • The same complaint alleges misuse of clinicians' NPI numbers to issue prescriptions without their knowledge or consent — the government's words are that Zealthy is "actively deceiving telehealth patients, endangering their safety, and raiding their bank accounts". These are allegations, not findings; the case is ongoing
  • Separately, and earlier: FDA warning letter #716501, dated September 9, 2025, to FitRX, LLC dba Zealthy, over the unlawful sale of unapproved and misbranded compounded semaglutide — the letter names getzealthy.com, and its address, 30 Irving Pl in New York, is the one the live site prints today

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

More head-to-heads

Keep comparing CoreAge Rx and Zealthy against other providers on our shortlist.

Or browse the full comparison hub.